These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38700999)
1. A Piecewise Design Approach to Engineering a Miniature ACE2 Mimic to Bind SARS-CoV-2. Vishweshwaraiah YL; Hnath B; Wang J; Chandler M; Mukherjee A; Yennawar NH; Booker SJ; Afonin KA; Dokholyan NV ACS Appl Bio Mater; 2024 May; 7(5):3238-3246. PubMed ID: 38700999 [TBL] [Abstract][Full Text] [Related]
2. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
3. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA Elife; 2021 Aug; 10():. PubMed ID: 34435953 [TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of ACE2 binding to coronavirus spike proteins: SARS-CoV-2 Li Z; Zhang JZH Phys Chem Chem Phys; 2021 Jun; 23(25):13926-13933. PubMed ID: 34137759 [TBL] [Abstract][Full Text] [Related]
6. In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2. Jafary F; Jafari S; Ganjalikhany MR Sci Rep; 2021 Mar; 11(1):6927. PubMed ID: 33767306 [TBL] [Abstract][Full Text] [Related]
7. Native Structure-Based Peptides as Potential Protein-Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor. Odolczyk N; Marzec E; Winiewska-Szajewska M; Poznański J; Zielenkiewicz P Molecules; 2021 Apr; 26(8):. PubMed ID: 33918595 [TBL] [Abstract][Full Text] [Related]
8. Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2. Larue RC; Xing E; Kenney AD; Zhang Y; Tuazon JA; Li J; Yount JS; Li PK; Sharma A Bioconjug Chem; 2021 Jan; 32(1):215-223. PubMed ID: 33356169 [TBL] [Abstract][Full Text] [Related]
9. Multivalent Display of SARS-CoV-2 Spike (RBD Domain) of COVID-19 to Nanomaterial, Protein Ferritin Nanocages. Kalathiya U; Padariya M; Fahraeus R; Chakraborti S; Hupp TR Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33671255 [TBL] [Abstract][Full Text] [Related]
10. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor. Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655 [TBL] [Abstract][Full Text] [Related]
11. Discovery of a Potential Allosteric Site in the SARS-CoV-2 Spike Protein and Targeting Allosteric Inhibitor to Stabilize the RBD Down State using a Computational Approach. Li T; Yan Z; Zhou W; Liu Q; Liu J; Hua H Curr Comput Aided Drug Des; 2024; 20(6):784-797. PubMed ID: 37493168 [TBL] [Abstract][Full Text] [Related]
12. Tinocordiside from Balkrishna A; Pokhrel S; Varshney A Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372 [TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions. Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP mBio; 2021 Mar; 12(2):. PubMed ID: 33785634 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of severe acute respiratory syndrome coronavirus 2 infection. Ge J; Zhang S; Zhang L; Wang X Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231 [TBL] [Abstract][Full Text] [Related]
15. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade. Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496 [TBL] [Abstract][Full Text] [Related]
17. Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2. Prévost J; Richard J; Gasser R; Ding S; Fage C; Anand SP; Adam D; Gupta Vergara N; Tauzin A; Benlarbi M; Gong SY; Goyette G; Privé A; Moreira S; Charest H; Roger M; Mothes W; Pazgier M; Brochiero E; Boivin G; Abrams CF; Schön A; Finzi A J Biol Chem; 2021 Oct; 297(4):101151. PubMed ID: 34478710 [TBL] [Abstract][Full Text] [Related]
18. Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice. Huang K; Zhang Y; Hui X; Zhao Y; Gong W; Wang T; Zhang S; Yang Y; Deng F; Zhang Q; Chen X; Yang Y; Sun X; Chen H; Tao YJ; Zou Z; Jin M EBioMedicine; 2021 May; 67():103381. PubMed ID: 33993052 [TBL] [Abstract][Full Text] [Related]
19. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides. Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962 [TBL] [Abstract][Full Text] [Related]
20. A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection. Miller A; Leach A; Thomas J; McAndrew C; Bentley E; Mattiuzzo G; John L; Mirazimi A; Harris G; Gamage N; Carr S; Ali H; Van Montfort R; Rabbitts T Sci Rep; 2021 May; 11(1):10617. PubMed ID: 34012108 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]